We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marrone Bio (MBII) Herbicides Enter Late-Stage Development
Read MoreHide Full Article
Marrone Bio Innovations Inc. recently announced that it is advancing three novel bioherbicides in its research and development (R&D) pipeline. This will further bolster its position as a leading provider of sustainable agricultural solutions. These biological-based herbicides are an essential component of the company’s strategic growth plan and will provide entry into the $27-billion weed control market.
The company has three proprietary bioherbicides in its R&D portfolio. The first two (MBI-005 and MBI-011) have prior regulatory approval from the U.S. Environmental Protection Agency and are undergoing further formulation refinement. The third, MBI-014/015, has progressed to advanced stages of development with current results indicating that it has herbicidal properties estimated to be 50-100 times more active than leading chemical alternatives.
The MBI family of bioherbicides can control the most economically significant and resistant weeds. These include annual broadleaves, grasses and sedges in major row crops as well as vegetable and turf markets. The bioherbicides can be utilized at various points in the growing season to give growers maximum flexibility to control weeds before, during and after planting.
The company’s R&D team has revealed roughly 500 herbicidal microbes from the more than 12,000 microbes screened that can be advanced through genomics, bioinformatics and synthetic biology systems. This broad range of microbes can potentially lead to the discovery of additional novel active ingredients and new modes of action.
These advancements further strengthen its leadership position as the supplier of choice for growers looking to meet the increasing demand for more responsibly grown food and fiber. The company’s family bioherbicides demonstrates how it is aggressively advancing its pipeline to provide a meaningful return on investment to farmers and investors alike, the company noted.
Shares of Marrone have declined 18.5% in the past year against a 19.1% rise of the industry.
Image Source: Zacks Investment Research
Marrone, in its last earnings call, stated that it expects a more normalized revenue growth rate in the second half of 2021. It sees revenue growth in the mid-teens and gross margins in the upper 50% range for the full year. It also expects operating expenses to remain in line with 2020 levels, adjusting for inflation.
Some better-ranked stocks in the basic materials space are Nucor Corporation (NUE - Free Report) , The Chemours Company (CC - Free Report) and Methanex Corporation (MEOH - Free Report) .
Nucor has a projected earnings growth rate of around 534.4% for the current year. The company’s shares have surged 106.3% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Chemours has an expected earnings growth rate of around 86.4% for the current year. The company’s shares have gained 33% in the past year. It currently carries a Zacks Rank #2 (Buy).
Methanex has an expected earnings growth rate of around 409.3% for the current fiscal. The company’s shares have surged 93.6% in the past year. It currently flaunts a Zacks Rank #1.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Marrone Bio (MBII) Herbicides Enter Late-Stage Development
Marrone Bio Innovations Inc. recently announced that it is advancing three novel bioherbicides in its research and development (R&D) pipeline. This will further bolster its position as a leading provider of sustainable agricultural solutions. These biological-based herbicides are an essential component of the company’s strategic growth plan and will provide entry into the $27-billion weed control market.
The company has three proprietary bioherbicides in its R&D portfolio. The first two (MBI-005 and MBI-011) have prior regulatory approval from the U.S. Environmental Protection Agency and are undergoing further formulation refinement. The third, MBI-014/015, has progressed to advanced stages of development with current results indicating that it has herbicidal properties estimated to be 50-100 times more active than leading chemical alternatives.
The MBI family of bioherbicides can control the most economically significant and resistant weeds. These include annual broadleaves, grasses and sedges in major row crops as well as vegetable and turf markets. The bioherbicides can be utilized at various points in the growing season to give growers maximum flexibility to control weeds before, during and after planting.
The company’s R&D team has revealed roughly 500 herbicidal microbes from the more than 12,000 microbes screened that can be advanced through genomics, bioinformatics and synthetic biology systems. This broad range of microbes can potentially lead to the discovery of additional novel active ingredients and new modes of action.
These advancements further strengthen its leadership position as the supplier of choice for growers looking to meet the increasing demand for more responsibly grown food and fiber. The company’s family bioherbicides demonstrates how it is aggressively advancing its pipeline to provide a meaningful return on investment to farmers and investors alike, the company noted.
Shares of Marrone have declined 18.5% in the past year against a 19.1% rise of the industry.
Marrone, in its last earnings call, stated that it expects a more normalized revenue growth rate in the second half of 2021. It sees revenue growth in the mid-teens and gross margins in the upper 50% range for the full year. It also expects operating expenses to remain in line with 2020 levels, adjusting for inflation.
Marrone Bio Innovations, Inc. Price and Consensus
Marrone Bio Innovations, Inc. price-consensus-chart | Marrone Bio Innovations, Inc. Quote
Zacks Rank & Key Picks
Marrone currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Nucor Corporation (NUE - Free Report) , The Chemours Company (CC - Free Report) and Methanex Corporation (MEOH - Free Report) .
Nucor has a projected earnings growth rate of around 534.4% for the current year. The company’s shares have surged 106.3% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Chemours has an expected earnings growth rate of around 86.4% for the current year. The company’s shares have gained 33% in the past year. It currently carries a Zacks Rank #2 (Buy).
Methanex has an expected earnings growth rate of around 409.3% for the current fiscal. The company’s shares have surged 93.6% in the past year. It currently flaunts a Zacks Rank #1.